Skip to main content

. 1981 Feb;43(2):226–228. doi: 10.1038/bjc.1981.32

M2 alpha-1-antitrypsin phenotype and primary liver cancer.

P Sizaret, M Clerc, J Estève, R R Frants, J Pillot

PMCID: PMC2010512 PMID: 6970588

226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Beaugrand M., Garnier J. P., Ferrier J. P., Buffet C., Vercaigne D., Martin J. P. L'association hépato-carcinome et déficit en alpha-1-antitrypsine existe-t-elle? A-t-elle un intérêt diagnostique? Nouv Presse Med. 1978 Mar 18;7(11):939–940. [PubMed] [Google Scholar]
Charlionet R., Martin J. P., Sesboué R., Ropartz C. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma? Biomedicine. 1976 Jun;25(4):125–126. [PubMed] [Google Scholar]
Clerc M., Le Bras M., Loubière R., Houvet D. Cancer primitif du foie: incidence du déficit en alpha-1-antitrypsine. Nouv Presse Med. 1977 Oct 15;6(34):3061–3064. [PubMed] [Google Scholar]
Cox D. W. Genetic variation of alpha 1-antitrypsin. Am J Hum Genet. 1978 Nov;30(6):660–662. [PMC free article] [PubMed] [Google Scholar]
Frants R. R., Noordhoek G. T., Eriksson A. W. Separator isoelectric focusing for identification of alpha-1-antitrypsin (Pi M) subtypes. Scand J Clin Lab Invest. 1978 Sep;38(5):457–462. doi: 10.3109/00365517809108451. [DOI] [PubMed] [Google Scholar]
Hammond M. G., Appadoo B., Brain P. HLA and cancer in South African Negroes. Tissue Antigens. 1977 Jan;9(1):1–7. doi: 10.1111/j.1399-0039.1977.tb01072.x. [DOI] [PubMed] [Google Scholar]
Oliver R. T. Histocompatibility antigens and human disease. Br J Hosp Med. 1977 Nov;18(5):449-52, 457-9. [PubMed] [Google Scholar]
Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer. A study in Swaziland. Int J Cancer. 1976 Feb 15;17(2):167–176. doi: 10.1002/ijc.2910170204. [DOI] [PubMed] [Google Scholar]
Simons M. J., Wee G. B., Day N. E., Morris P. J., Shanmugaratnam K., De-Thé G. B. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer. 1974 Jan 15;13(1):122–134. doi: 10.1002/ijc.2910130114. [DOI] [PubMed] [Google Scholar]
Sizaret P., Tuyns A., Martel N., Jouvenceaux A., Levin A., Ong Y. W., Rive J. Alpha-Fetoprotein levels in normal males from seven ethnic groups with different hepatocellular carcinoma risks. Ann N Y Acad Sci. 1975 Aug 22;259:136–155. doi: 10.1111/j.1749-6632.1975.tb25410.x. [DOI] [PubMed] [Google Scholar]
Theodoropoulos G., Fertakis A., Archimandritis A., Kapordelis C., Angelopoulos B. Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma. Acta Hepatogastroenterol (Stuttg) 1976 Apr;23(2):114–117. [PubMed] [Google Scholar]
Theodoropoulos G., Rigatos G., Babionitakis A., Archimandritis A., Fertakis A., Melissinos K. Serum Gc system in liver cirrhosis and hepatoma. Hum Genet. 1977 Nov 10;39(2):225–228. doi: 10.1007/BF00287016. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES